Federal contract award
W81K0421F0013
COVID-19 PANTHER FUSION TEST KITS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M USA HCA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | W81K0420D0007 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $16.2M |
| Current contract value | $16.2M |
| Potential contract value / ceiling | $16.2M |
| Start date | Jan 20, 2021 |
| Current end date | Jan 19, 2022 |
| Potential end date | Jan 19, 2022 |
| Latest award activity | Sep 23, 2021 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 23, 2021 | P00004 | $-3.8M | APTIMA SARS-COV-2 ASSAY KIT (COVID-19 TEST KITS) IN THE SUPPORT OF OTSG. |
| Apr 14, 2021 | P00003 | $0 | PERIOD OF PERFORMANCE EXTENSION ALLOWING THE DELIVERY OF FURTHER TEST KITS |
| Mar 10, 2021 | P00002 | $-46 | KIT, DNA/RNA ENZYME CARTRIDGE |
| Feb 4, 2021 | P00001 | $0 | COVID-19 PANTHER FUSION TEST KITS TO UPDATE CLIN 0014 DESCRIPTION. |
| Jan 20, 2021 | 0 | $20.0M | COVID-19 PANTHER FUSION TEST KITS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.